Veradigm EPS - Earnings per Share 2011-2022 | MDRX
Veradigm eps - earnings per share from 2011 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Veradigm Annual EPS | |
|---|---|
| 2022 | $-0.77 |
| 2021 | $1.01 |
| 2020 | $4.37 |
| 2019 | $-1.10 |
| 2018 | $2.07 |
| 2017 | $-1.09 |
| 2016 | $-0.14 |
| 2015 | $-0.01 |
| 2014 | $-0.37 |
| 2013 | $-0.59 |
| 2012 | $-0.01 |
| 2011 | $0.39 |
| 2010 | $-0.03 |
| Veradigm Quarterly EPS | |
|---|---|
| 2022-12-31 | $-0.52 |
| 2022-09-30 | $0.12 |
| 2022-06-30 | $-0.54 |
| 2022-03-31 | $0.17 |
| 2021-12-31 | $0.68 |
| 2021-09-30 | $0.12 |
| 2021-06-30 | $0.15 |
| 2021-03-31 | $0.06 |
| 2020-12-31 | $4.55 |
| 2020-09-30 | $0.00 |
| 2020-06-30 | $-0.05 |
| 2020-03-31 | $-0.13 |
| 2019-12-31 | $-0.13 |
| 2019-09-30 | $-0.03 |
| 2019-06-30 | $-0.90 |
| 2019-03-31 | $-0.04 |
| 2018-12-31 | $2.13 |
| 2018-09-30 | $-0.20 |
| 2018-06-30 | $0.36 |
| 2018-03-31 | $-0.22 |
| 2017-12-31 | $0.03 |
| 2017-09-30 | $-0.16 |
| 2017-06-30 | $-0.85 |
| 2017-03-31 | $-0.11 |
| 2016-12-31 | $-0.04 |
| 2016-09-30 | $-0.06 |
| 2016-06-30 | $-0.05 |
| 2016-03-31 | $0.01 |
| 2015-12-31 | $0.09 |
| 2015-09-30 | $-0.03 |
| 2015-06-30 | $-0.01 |
| 2015-03-31 | $-0.06 |
| 2014-12-31 | $-0.01 |
| 2014-09-30 | $-0.15 |
| 2014-06-30 | $-0.09 |
| 2014-03-31 | $-0.12 |
| 2013-12-31 | $-0.12 |
| 2013-09-30 | $-0.27 |
| 2013-06-30 | $-0.13 |
| 2013-03-31 | $-0.07 |
| 2012-12-31 | $-0.13 |
| 2012-09-30 | $0.05 |
| 2012-06-30 | $0.04 |
| 2012-03-31 | $0.03 |
| 2011-12-31 | $0.14 |
| 2011-09-30 | $0.10 |
| 2011-06-30 | $0.08 |
| 2011-03-31 | $0.07 |
| 2010-12-31 | $-0.03 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.523B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $49.025B | 59.82 |
| Tempus AI (TEM) | United States | $12.432B | 0.00 |
| Doximity (DOCS) | United States | $9.874B | 40.87 |
| Hims & Hers Health (HIMS) | United States | $9.049B | 73.61 |
| IRhythm Technologies (IRTC) | United States | $5.681B | 0.00 |
| Hinge Health (HNGE) | United States | $3.475B | 0.00 |
| Privia Health (PRVA) | United States | $2.991B | 187.08 |
| Heartflow (HTFL) | United States | $2.850B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.632B | 43.55 |
| 10x Genomics (TXG) | United States | $2.065B | 0.00 |
| Enovis (ENOV) | United States | $1.802B | 9.46 |
| Omnicell (OMCL) | United States | $1.665B | 34.05 |
| Azenta (AZTA) | United States | $1.405B | 61.32 |
| Phreesia (PHR) | United States | $1.363B | 0.00 |
| Schrodinger (SDGR) | United States | $1.347B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.307B | 0.00 |
| Claritev (CTEV) | United States | $0.943B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.877B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.621B | 0.00 |
| Evolent Health (EVH) | United States | $0.592B | 0.00 |
| Talkspace (TALK) | United States | $0.585B | 117.67 |
| Standard BioTools (LAB) | United States | $0.458B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.381B | 0.00 |
| Carlsmed (CARL) | United States | $0.324B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.312B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| CapsoVision (CV) | United States | $0.255B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.210B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.192B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.190B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.172B | 0.00 |
| CareCloud (CCLD) | United States | $0.140B | 7.70 |
| EUDA Health Holdings (EUDA) | Singapore | $0.116B | 0.00 |
| Outset Medical (OM) | United States | $0.113B | 0.00 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.054B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |